Literature DB >> 10614835

Time course of free radical production after primary coronary angioplasty for acute myocardial infarction and the effect of vitamin C.

W Guan1, T Osanai, T Kamada, H Ishizaka, H Hanada, K Okumura.   

Abstract

Reactive oxygen species are thought to mediate reperfusion injury after rapid revascularization for acute myocardial infarction (AMI) and 8-epi prostaglandin (PG) F2alpha, a free-radical catalyzed product of arachidonic acid, has been proposed as an indicator of oxidative stress in vivo during myocardial reperfusion. The time course of urinary 8-epi PGF2alpha excretion after primary coronary angioplasty (PTCA) for AMI was investigated, as well as the effect of prior administration of vitamin C. Urine samples, 1 before and 5 after primary PTCA (0-30, 30-60, 60-90, 90-120 and 120-150 min), were collected in 11 patients with AMI undergoing primary PTCA (Group 1), 10 patients with AMI treated with water-soluble vitamin C at an initial dose of 2.0 g followed by a constant infusion at 20mg/min prior to primary PTCA (Group 2), and 6 patients with stable effort angina undergoing elective PTCA (Group 3). 8-epi PGF2alpha was measured by enzyme immunoassay. There were no significant differences in urinary 8-epi PGF2alpha excretion at baseline among the 3 groups. In Group 1, urinary 8-epi PGF2alpha excretion (ng/mmol creatinine) significantly increased from 60+/-8 at baseline to 122+/-16 at 60-90 min (p<0.001), and declined to the baseline level at 120-150 min after primary PTCA. In Group 2, it also increased from 72+/-12 to 123+/-15 at 60-90 min (p<0.01), and the percent increase did not differ from that in Group 1. In Group 3, it remained unchanged during the study period. The free radical production is rapidly and transiently enhanced after primary PTCA for AMI, and vitamin C fails to suppress it.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10614835     DOI: 10.1253/jcj.63.924

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  8 in total

Review 1.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

2.  Vitamin C and percutaneous coronary intervention.

Authors:  Patrice Delafontaine; Asif Anwar
Journal:  JACC Cardiovasc Interv       Date:  2010-02       Impact factor: 11.195

Review 3.  Pharmacological Basis for Abrogating Myocardial Reperfusion Injury Through a Multi-Target Combined Antioxidant Therapy.

Authors:  Daniel San-Martín-Martínez; Dayanara Serrano-Lemus; Vicente Cornejo; Abraham I J Gajardo; Ramón Rodrigo
Journal:  Clin Pharmacokinet       Date:  2022-07-25       Impact factor: 5.577

4.  Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant system.

Authors:  Ramón Rodrigo
Journal:  Front Physiol       Date:  2012-04-12       Impact factor: 4.566

5.  Vitamin C for Cardiac Protection during Percutaneous Coronary Intervention: A Systematic Review of Randomized Controlled Trials.

Authors:  Sher Ali Khan; Sandipan Bhattacharjee; Muhammad Owais Abdul Ghani; Rachel Walden; Qin M Chen
Journal:  Nutrients       Date:  2020-07-23       Impact factor: 5.717

6.  Vitamin C May Improve Left Ventricular Ejection Fraction: A Meta-Analysis.

Authors:  Harri Hemilä; Elizabeth Chalker; Angelique M E de Man
Journal:  Front Cardiovasc Med       Date:  2022-02-25

7.  The effectiveness of antioxidant vitamins C and E in reducing myocardial infarct size in patients subjected to percutaneous coronary angioplasty (PREVEC Trial): study protocol for a pilot randomized double-blind controlled trial.

Authors:  Ramón Rodrigo; Daniel Hasson; Juan C Prieto; Gastón Dussaillant; Cristóbal Ramos; Lucio León; Javier Gárate; Nicolás Valls; Juan G Gormaz
Journal:  Trials       Date:  2014-05-29       Impact factor: 2.279

Review 8.  Making sense of early high-dose intravenous vitamin C in ischemia/reperfusion injury.

Authors:  Angelique M E Spoelstra-de Man; Paul W G Elbers; Heleen M Oudemans-van Straaten
Journal:  Crit Care       Date:  2018-03-20       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.